Iovance Biotherapeutics Statistics

Total Valuation

IOVA has a market cap or net worth of $2.25 billion. The enterprise value is $1.93 billion.

Market Cap	2.25B
Enterprise Value	1.93B

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

IOVA has 304.78 million shares outstanding. The number of shares has increased by 30.80% in one year.

Current Share Class	304.78M
Shares Outstanding	304.78M
Shares Change (YoY)	+30.80%
Shares Change (QoQ)	+6.48%
Owned by Insiders (%)	9.63%
Owned by Institutions (%)	61.71%
Float	224.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.55
Forward PS	6.07
PB Ratio	2.91
P/TBV Ratio	4.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	21.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.10.

Current Ratio	4.22
Quick Ratio	3.84
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -56.65% and return on invested capital (ROIC) is -33.47%.

Return on Equity (ROE)	-56.65%
Return on Assets (ROA)	-29.15%
Return on Capital (ROIC)	-33.47%
Revenue Per Employee	$163,120
Profits Per Employee	-$736,081
Employee Count	557
Asset Turnover	0.10
Inventory Turnover	3.47

Taxes

Income Tax	-6.15M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.63% in the last 52 weeks. The beta is 0.53, so IOVA's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-5.63%
50-Day Moving Average	9.41
200-Day Moving Average	10.25
Relative Strength Index (RSI)	32.93
Average Volume (20 Days)	5,812,641

Short Selling Information

The latest short interest is 56.92 million, so 18.67% of the outstanding shares have been sold short.

Short Interest	56.92M
Short Previous Month	53.99M
Short % of Shares Out	18.67%
Short % of Float	25.32%
Short Ratio (days to cover)	6.73

Income Statement

In the last 12 months, IOVA had revenue of $90.86 million and -$410.00 million in losses. Loss per share was -$1.48.

Revenue	90.86M
Gross Profit	8.04M
Operating Income	-429.96M
Pretax Income	-446.08M
Net Income	-410.00M
EBITDA	-408.32M
EBIT	-429.96M
Loss Per Share	-$1.48

Full Income Statement

Balance Sheet

The company has $397.49 million in cash and $78.94 million in debt, giving a net cash position of $318.55 million or $1.05 per share.

Cash & Cash Equivalents	397.49M
Total Debt	78.94M
Net Cash	318.55M
Net Cash Per Share	$1.05
Equity (Book Value)	773.46M
Book Value Per Share	2.54
Working Capital	380.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$363.65 million and capital expenditures -$10.43 million, giving a free cash flow of -$374.08 million.

Operating Cash Flow	-363.65M
Capital Expenditures	-10.43M
Free Cash Flow	-374.08M
FCF Per Share	-$1.23

Full Cash Flow Statement

Margins

Gross Margin	8.85%
Operating Margin	-473.22%
Pretax Margin	-458.01%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IOVA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-30.80%
Shareholder Yield	-30.80%
Earnings Yield	-18.23%
FCF Yield	-16.63%

Dividend Details

Analyst Forecast

The average price target for IOVA is $23.33, which is 216.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.33
Price Target Difference	216.13%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	230.16%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 26, 2013. It was a reverse split with a ratio of 0.01:1.

Last Split Date	Sep 26, 2013
Split Type	Reverse
Split Ratio	0.01:1

Scores

IOVA has an Altman Z-Score of 2.92 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.92
Piotroski F-Score	4